These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30666031)

  • 1. Determination of the antibiotic resistance rates of
    Simsek M
    Niger J Clin Pract; 2019 Jan; 22(1):125-130. PubMed ID: 30666031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of extended-spectrum beta-lactamase producing Serratia marcescens in an intensive care unit.
    Pagani L; Luzzaro F; Ronza P; Rossi A; Micheletti P; Porta F; Romero E
    FEMS Immunol Med Microbiol; 1994 Nov; 10(1):39-46. PubMed ID: 7874077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance of Serratia marcescens causing blood stream infections in a large University Hospital in Bulgaria, an 8-year analysis (2016-2023).
    Radeva S; Niyazi D; Bozhkova M; Stoeva T
    Acta Microbiol Immunol Hung; 2024 Sep; 71(3):191-196. PubMed ID: 39088273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan.
    Liou BH; Duh RW; Lin YT; Lauderdale TL; Fung CP;
    J Microbiol Immunol Infect; 2014 Oct; 47(5):387-93. PubMed ID: 23751769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
    Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
    Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan.
    Wu LT; Tsou MF; Wu HJ; Chen HE; Chuang YC; Yu WL
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):125-9. PubMed ID: 15183862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    Hemarajata P; Amick T; Yang S; Gregson A; Holzmeyer C; Bush K; Humphries RM
    J Antimicrob Chemother; 2018 May; 73(5):1256-1262. PubMed ID: 29471486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of Serratia marcescens.
    Luzzaro F; Pagani L; Porta F; Romero E
    J Chemother; 1995 Jun; 7(3):175-8. PubMed ID: 7562009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of Serratia marcescens Coproducing ArmA and CTX-M-15 Mediated High Levels of Resistance to Aminoglycoside and Extended-Spectrum Beta-Lactamases, Algeria.
    Batah R; Loucif L; Olaitan AO; Boutefnouchet N; Allag H; Rolain JM
    Microb Drug Resist; 2015 Aug; 21(4):470-6. PubMed ID: 25884511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.
    Biagi M; Shajee A; Vialichka A; Jurkovic M; Tan X; Wenzler E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful management with fosfomycin + ceftazidime of an infection caused by multiple highly-related subtypes of multidrug-resistant and extensively drug-resistant KPC-producing Serratia marcescens.
    Rodríguez C; Brengi S; Cáceres MA; Mochi S; Viñas MR; Rizza CA; Merletti G; Bru E; Assa JD; Raya RR; Centrón D
    Int J Antimicrob Agents; 2018 Nov; 52(5):737-739. PubMed ID: 30092272
    [No Abstract]   [Full Text] [Related]  

  • 19. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates.
    Yu WL; Lin CW; Wang DY
    J Microbiol Immunol Infect; 1998 Sep; 31(3):171-9. PubMed ID: 10496154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-mediated quinolone resistance in extended-spectrum-β-lactamase- and AmpC β-lactamase-producing Serratia marcescens in China.
    Yang HF; Cheng J; Hu LF; Ye Y; Li JB
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4529-31. PubMed ID: 22664965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.